Related Experiment Videos

Intranasal versed: the future of pediatric conscious sedation

Pediatric Nursing
|May 1, 1994
PubMed

Insights

Pediatric procedural sedation is common. This review covers intranasal midazolam and flumazenil, focusing on nursing awareness of American Academy of Pediatrics (AAP) guidelines and medication trends.

Area of Science:

  • Pediatric Anesthesiology
  • Emergency Medicine
  • Pediatric Nursing

Background:

  • Conscious sedation for pediatric procedures is increasingly utilized in diverse healthcare settings.
  • Nurses require updated knowledge on sedation guidelines and pharmacologic trends.
  • Safe and effective sedation practices are paramount for pediatric patient care.

Purpose of the Study:

  • To review current American Academy of Pediatrics (AAP) guidelines for pediatric conscious sedation.
  • To examine contemporary trends in pharmacologic agents used for pediatric sedation.
  • To analyze the pediatric applications and existing literature on intranasal midazolam and flumazenil.

Main Methods:

  • Literature review of pediatric conscious sedation.
  • Analysis of current AAP sedation guidelines.
  • Review of studies on intranasal midazolam and flumazenil efficacy and safety in children.

Main Results:

  • Intranasal midazolam offers a viable route for procedural sedation in pediatric patients.
  • Flumazenil serves as a potential reversal agent for benzodiazepine-induced sedation.
  • Evidence supports the use of these agents within established guidelines.

Conclusions:

  • Nurses must stay informed about AAP guidelines and evolving sedation medications.
  • Intranasal midazolam and flumazenil represent important options for pediatric procedural sedation.
  • Adherence to guidelines ensures optimal patient safety and procedural success.

Related Concept Videos